TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ) has provided an update.
Jubilant Pharmova Limited’s Board of Directors has approved the grant of 1,506 Stock Options/Restricted Stock Units (RSUs) to eligible employees under the Jubilant Pharmova Employees Stock Option Plan 2018. This move is part of the company’s strategy to incentivize and retain talent, potentially impacting employee motivation and aligning their interests with the company’s long-term goals.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited operates in the pharmaceutical industry, focusing on the development, manufacture, and distribution of pharmaceutical products. The company is known for its wide range of products and services catering to various healthcare needs.
Average Trading Volume: 8,283
Technical Sentiment Signal: Buy
Current Market Cap: 178.3B INR
For an in-depth examination of JUBLPHARMA stock, go to TipRanks’ Overview page.